Michal Kolařík , Kayhan Ilbeigi , Guy Caljon , Lucie Brulíková
{"title":"噻唑烷酮类及相关类似物作为有效的抗锥虫药物","authors":"Michal Kolařík , Kayhan Ilbeigi , Guy Caljon , Lucie Brulíková","doi":"10.1016/j.bmc.2025.118363","DOIUrl":null,"url":null,"abstract":"<div><div>We designed and synthesised a series of thiazolidinediones and related analogues and evaluated their antiparasitic activity. A structure-activity relationship (SAR) study focused on modifications of specific parts of the molecule revealed derivatives that displayed significant activity against <em>Trypanosoma brucei</em> species. Notably, the analogue <strong>6i</strong> exhibited exceptional activity, with an EC<sub>50</sub> value of 30 nM and a selectivity index of >2000, against the protozoan <em>Trypanosoma brucei rhodesiense</em>, which causes human African trypanosomiasis. Additionally, compounds <strong>6a</strong>, <strong>6k</strong>, <strong>7e</strong>, and <strong>18</strong> demonstrated antitrypanosomal activities in the less than 5 μM range. Our most active analogue <strong>6i</strong> represents a promising candidate for further preclinical development.</div></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"130 ","pages":"Article 118363"},"PeriodicalIF":3.0000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Thiazolidinones and related analogues as efficient antitrypanosomal agents\",\"authors\":\"Michal Kolařík , Kayhan Ilbeigi , Guy Caljon , Lucie Brulíková\",\"doi\":\"10.1016/j.bmc.2025.118363\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>We designed and synthesised a series of thiazolidinediones and related analogues and evaluated their antiparasitic activity. A structure-activity relationship (SAR) study focused on modifications of specific parts of the molecule revealed derivatives that displayed significant activity against <em>Trypanosoma brucei</em> species. Notably, the analogue <strong>6i</strong> exhibited exceptional activity, with an EC<sub>50</sub> value of 30 nM and a selectivity index of >2000, against the protozoan <em>Trypanosoma brucei rhodesiense</em>, which causes human African trypanosomiasis. Additionally, compounds <strong>6a</strong>, <strong>6k</strong>, <strong>7e</strong>, and <strong>18</strong> demonstrated antitrypanosomal activities in the less than 5 μM range. Our most active analogue <strong>6i</strong> represents a promising candidate for further preclinical development.</div></div>\",\"PeriodicalId\":255,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry\",\"volume\":\"130 \",\"pages\":\"Article 118363\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968089625003049\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089625003049","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Thiazolidinones and related analogues as efficient antitrypanosomal agents
We designed and synthesised a series of thiazolidinediones and related analogues and evaluated their antiparasitic activity. A structure-activity relationship (SAR) study focused on modifications of specific parts of the molecule revealed derivatives that displayed significant activity against Trypanosoma brucei species. Notably, the analogue 6i exhibited exceptional activity, with an EC50 value of 30 nM and a selectivity index of >2000, against the protozoan Trypanosoma brucei rhodesiense, which causes human African trypanosomiasis. Additionally, compounds 6a, 6k, 7e, and 18 demonstrated antitrypanosomal activities in the less than 5 μM range. Our most active analogue 6i represents a promising candidate for further preclinical development.
期刊介绍:
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.
The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.